When dogs develop cancer, quality of life assessment becomes central to treatment decisions and knowing when to pursue palliative rather than curative care.
Cancer treatment decisions in dogs must balance potential benefit against treatment burden. Chemotherapy in dogs generally causes less severe side effects than in humans, but quality of life throughout treatment must be monitored. The endpoint of treatment should always be the dog's wellbeing, not prolonging life at any cost.